Skip to content

Verification test of Bifidobacterium bifidum F1000 survival in human digestive tract - Open method -

Verification test of Bifidobacterium bifidum F1000 survival in human digestive tract - Open method - - Verification test of Bifidobacterium bifidum F1000 survival in human digestive tract

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000038770
Enrollment
10
Registered
2020-12-27
Start date
2019-11-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Take Biofermin Lactic acid bacteria Supplements three times a day, one after meals, for 6 days.

Sponsors

KSO Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Males and females from 20 to 64 years of age who have daily defecation. (2)Subjects who usually have three meals a day. (3)Subjects who can make self-judgment and are voluntarily giving written informed consent.

Exclusion criteria

Exclusion criteria: (1)Subjects who having been taken intestinal preparation and/or antibacterial drug within 2 weeks at the point of screening examination. (2)Subjects who taking medicine. (3)Subjects who taking health foods that are said to improve constipation at the point of screening examination. (4)Subjects who are not able to stop consumption of foods containing lactic acid bacteria, bifidobacteria, natto bacteria, oligosaccharides, dietary fibers, high amount of sugar alcohol and/or other health foods including food for specified health use, which influence intestinal regulation during the study period. (5)Subjects with a digestive organ disease or surgical history who has an influence on digestive absorption and defecation. (6)Subjects who are pregnant or breast-feeding, or have the will of pregnancy during the study period. (7)Subjects who participate in other clinical studies or who are in willing to participate to these studies using foods, drugs and/or cosmetics. (8)Subjects who are judged as unsuitable for the study by the investigator for the other reasons.

Design outcomes

Primary

MeasureTime frame
Detection of viable bacteria of Bifidobacterium bifidum F1000 in feces

Secondary

MeasureTime frame
Interview Self-resevotable symptom

Countries

Japan

Contacts

Public ContactYoshika Komori

KSO Corporation Sales Department

yoshi@kso.co.jp03-3452-7733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026